Motherhood, Pregnancy and Breast Cancer

0
Meghan Martin and her husband, Patrick

Meghan Martin and her husband, Patrick

While visiting her obstetrician in May 2012, 30-year-old Meghan Martin received life-changing news. The mother of two, who was seven-months pregnant with her third boy, learned she had breast cancer.

“My first thoughts were: Will this baby live? Will I Live? Who is going to read bedtime stores?” Martin says.

A day later, Martin began planning her treatment with the Program for Young Women with Breast Cancer at the Susan F. Smith Center for Women’s Cancers at Dana-Farber. She had four doses of chemotherapy before giving birth to her “miracle baby,” Gavin. Martin continued her treatment a short while after Gavin arrived, all while maintaining her role as a mother to her newborn, 2-year-old and 4-year-old boys.

Martin recently spoke about her experience at the Susan F. Smith Center Executive Council Breakfast. Hear her story in the video below:

Comments Sort By Newest

Leave a Reply

Your email address will not be published. Required fields are marked *

Blue Captcha Image
Refresh

*

Latest Tweets

Dana-Farber @danafarber
Five Things Young Women with Breast Cancer Should Know: https://t.co/5KKrrwqAK6 #bcan #bcsm
Dana-Farber @danafarber
Pancreatic cancer and genetic risk - what you need to know: https://t.co/2eEEchh08N #genetics
Dana-Farber @danafarber
Join our breast cancer experts at our annual Metastatic Breast Cancer Forum 9/24: https://t.co/vcuTa0x7n4 #bcsm #bcmets

Make An Appointment

For adults: 877-442-3324

Quick access: Appointments as soon as the next day for new adult patients

For children: 888-733-4662

Republish our posts on your blog

Interested in sharing one of our stories on your blog? Feel free to republish this content! We just ask that you credit Dana-Farber, link to the original article, and refrain from making edits that change the original context. Questions? Email the editors at insight_blog@dfci.harvard.edu.

All content in these blogs is provided by independent writers and does not represent the opinions or advice of Dana-Farber Cancer Institute or its partners.